The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial

for the GS-US-384-1497 Investigators

Research output: Contribution to journalArticlepeer-review

232 Scopus citations

Fingerprint

Dive into the research topics of 'The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences